GBT

Global Blood Therapeutics, Inc.
GBT

Overview Fund Activity
Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

157 hedge funds and large institutions have $1.71B invested in Global Blood Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 49 increasing their positions, 51 reducing their positions, and 26 closing their positions.

Holders
157
Holders Change
+21
Holders Change %
+15.44%
% of All Funds
3.57%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.2%
New
47
Increased
49
Reduced
51
Closed
26
Calls
$49.5M
Puts
$29.1M
Net Calls
+$20.4M
Net Calls Change
+$10M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$119M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$76M
3
CCM
3
Camber Capital Management
Massachusetts
$31.5M
4
ACA
4
Avoro Capital Advisors
New York
$72.5M
5
PA
5
Perceptive Advisors
New York
$192M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$8.91M
2
AC
2
Ascend Capital
California
$0
3
Deutsche Bank
3
Deutsche Bank
Germany
$5.34M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$83.7M
5
O
5
OrbiMed
New York
$84.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
Balyasny Asset Management
176
Balyasny Asset Management
Illinois
– -$269K -8,677 Closed
QSS
177
Quantitative Systematic Strategies
Florida
– -$237K -7,635 Closed
DTL
178
Dynamic Technology Lab
Singapore
– -$205K -6,627 Closed
TI
179
Trexquant Investment
Connecticut
– -$202K -6,518 Closed
FAM
180
Fred Alger Management
New York
– -$93K -3,000 Closed
PHK
181
Point72 Hong Kong
Hong Kong
– -$19K -615 Closed
HCM
182
Highlander Capital Management
New Jersey
– -$9K -300 Closed
IWM
183
IHT Wealth Management
Illinois
– -$1K -19 Closed
4 5 6 7
8